These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35662611)

  • 21. Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.
    Rama Chandran S; Tay WL; Lye WK; Lim LL; Ratnasingam J; Tan ATB; Gardner DSL
    Diabetes Technol Ther; 2018 May; 20(5):353-362. PubMed ID: 29688755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
    Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control.
    Šoupal J; Škrha J; Fajmon M; Horová E; Mráz M; Škrha J; Prázný M
    Diabetes Technol Ther; 2014 Apr; 16(4):198-203. PubMed ID: 24401008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous glucose monitoring to assess glucose variability in type 3c diabetes.
    Lee VTY; Poynten A; Depczynski B
    Diabet Med; 2022 Aug; 39(8):e14882. PubMed ID: 35569007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Largest Amplitude of Glycemic Excursion Calculating from Self-Monitoring Blood Glucose Predicted the Episodes of Nocturnal Asymptomatic Hypoglycemia Detecting by Continuous Glucose Monitoring in Outpatients with Type 2 Diabetes.
    Wang S; Tan Z; Wu T; Shen Q; Huang P; Wang L; Liu W; Song H; Lin M; Shi X; Li X
    Front Endocrinol (Lausanne); 2022; 13():858912. PubMed ID: 35498416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct Patterns of Daily Glucose Variability by Pubertal Status in Youth With Type 1 Diabetes.
    Zhu J; Volkening LK; Laffel LM
    Diabetes Care; 2020 Jan; 43(1):22-28. PubMed ID: 31308020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
    Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
    Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
    [No Abstract]   [Full Text] [Related]  

  • 28. Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes.
    Lu J; Ma X; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Zhou J
    J Diabetes Investig; 2019 May; 10(3):753-759. PubMed ID: 30306722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved Estimation of Glycated Hemoglobin from Continuous Glucose Monitoring and Past Glycated Hemoglobin Data.
    Chrzanowski J; Michalak A; Łosiewicz A; Kuśmierczyk H; Mianowska B; Szadkowska A; Fendler W
    Diabetes Technol Ther; 2021 Apr; 23(4):293-305. PubMed ID: 33112161
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of Reference Metrics for Continuous Glucose Monitoring in Persons Without Diabetes and Prediabetes.
    Sofizadeh S; Pehrsson A; Ólafsdóttir AF; Lind M
    J Diabetes Sci Technol; 2022 Mar; 16(2):373-382. PubMed ID: 33100059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of visit-to-visit glycemic variability on the risks of major adverse cardiovascular outcomes and hypoglycemia in patients with different glycemic control and type 2 diabetes.
    Sun B; He F; Gao Y; Zhou J; Sun L; Liu R; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jun; 64(3):536-543. PubMed ID: 30868413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.
    Bomholt T; Feldt-Rasmussen B; Butt R; Borg R; Sarwary MH; Elung-Jensen T; Almdal T; Knop FK; Nørgaard K; Ranjan AG; Larsson A; Rix M; Hornum M
    Nephron; 2022; 146(2):146-152. PubMed ID: 34731864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.
    Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC
    PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of visit-to-visit glycemic variability with risk of cardiovascular diseases in high-risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial.
    Sato M; Inaishi J; Saisho Y; Sato Y; Komuro I; Itoh H
    J Diabetes Investig; 2021 Dec; 12(12):2190-2196. PubMed ID: 34013644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study).
    Bae JC; Kwak SH; Kim HJ; Kim SY; Hwang YC; Suh S; Hyun BJ; Cha JE; Won JC; Kim JH
    Diabetes Metab J; 2022 Jan; 46(1):81-92. PubMed ID: 34130378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration.
    Piona C; Marigliano M; Mozzillo E; Franzese A; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
    Pediatr Diabetes; 2020 Dec; 21(8):1485-1492. PubMed ID: 32935887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between daily and visit-to-visit glycemic variability in patients with type 2 diabetes.
    Tsuchiya T; Saisho Y; Murakami R; Watanabe Y; Inaishi J; Itoh H
    Endocr J; 2020 Aug; 67(8):877-881. PubMed ID: 32389920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterising frailty, metrics of continuous glucose monitoring, and mortality hazards in older adults with type 2 diabetes on insulin therapy (HARE): a prospective, observational cohort study.
    Fung E; Lui LT; Huang L; Cheng KF; Lau GHW; Chung YT; Ahmadabadi BN; Xie S; Lee JSW; Hui E; So WY; Sung JJY; King I; Goggins WB; Chan Q; Järvelin MR; Ma RCW; Chow E; Kwok T
    Lancet Healthy Longev; 2021 Nov; 2(11):e724-e735. PubMed ID: 36098029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycemic variability modifies the relationship between time in range and hemoglobin A1c estimated from continuous glucose monitoring: A preliminary study.
    Lu J; Ma X; Zhang L; Mo Y; Lu W; Zhu W; Bao Y; Jia W; Zhou J
    Diabetes Res Clin Pract; 2020 Mar; 161():108032. PubMed ID: 32006646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control.
    Yoshii H; Mita T; Katakami N; Okada Y; Osonoi T; Aso K; Kurozumi A; Wakasugi S; Sato F; Ishii R; Gosho M; Shimomura I; Watada H
    J Clin Endocrinol Metab; 2022 Sep; 107(10):e3990-e4003. PubMed ID: 35908248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.